Testing effectiveness (Phase 2)UnknownNCT02562365What this trial is testingAdjuvant Chemotherapy of Three-step Regimen in Ovarian CancerWho this might be right forOvarian Cancer Xiaohua Wu MD 130
Very early researchActive Not RecruitingNCT05415709What this trial is testingHyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous Adenocarcinoma+30 more Ohio State University Comprehensive Cancer Center 35
Very early researchStudy completedNCT02111941What this trial is testingVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more Mayo Clinic 19
Large-scale testing (Phase 3)WithdrawnNCT00693342What this trial is testingVaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete RemissionWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Large-scale testing (Phase 3)UnknownNCT03693248What this trial is testingReduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerWho this might be right forOvarian Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer+1 more Seoul National University Hospital 298
Not applicableUnknownNCT01366183What this trial is testingChemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerWho this might be right forStage I Ovarian Cancer AJCC v6 and v7Stage IA Fallopian Tube Cancer AJCC v6 and v7Stage IB Fallopian Tube Cancer AJCC v6 and v7+13 more Gynecologic Oncology Group 290
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Looking for participantsNCT04575935What this trial is testingMinimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialWho this might be right forAdvanced Ovarian CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Tumor+22 more M.D. Anderson Cancer Center 580
Early research (Phase 1)Study completedNCT00562640What this trial is testingAutologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)Who this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)WithdrawnNCT02833506What this trial is testingSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+18 more Roswell Park Cancer Institute
Large-scale testing (Phase 3)Active Not RecruitingNCT02859038What this trial is testingStudy of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)Who this might be right forEpithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma Shanghai Gynecologic Oncology Group 489
Testing effectiveness (Phase 2)Study completedNCT02122185What this trial is testingMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forBrenner TumorMalignant AscitesMalignant Pleural Effusion+25 more University of Chicago 111
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Not applicableUnknownNCT01372787What this trial is testingQuality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal CancerWho this might be right forAnxietyFatigueNausea and Vomiting+20 more Gynecologic Oncology Group 103
Very early researchWithdrawnNCT02872519What this trial is testingPET Imaging of Ovarian Carcinoma With 18F-FSPGWho this might be right forStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Primary Peritoneal Cancer+9 more Vanderbilt-Ingram Cancer Center
Not applicableStudy completedNCT01982500What this trial is testingObservation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian CancerWho this might be right forOvarian Cancer Hellenic Oncology Research Group 200
Testing effectiveness (Phase 2)UnknownNCT02125513What this trial is testingNeoadjuvant Chemotherapy in Epithelial Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CarcinomaPeritoneal Carcinoma IRCCS Azienda Ospedaliero-Universitaria di Bologna 129
Early research (Phase 1)WithdrawnNCT04498520What this trial is testingAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more Pamela Munster
Testing effectiveness (Phase 2)Study completedNCT00388037What this trial is testingSunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forRecurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+12 more National Cancer Institute (NCI) 31
Not applicableStudy completedNCT02315469What this trial is testingComprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing SurgeryWho this might be right forEndometrial Serous AdenocarcinomaFallopian Tube CarcinomaMalignant Female Reproductive System Neoplasm+7 more NRG Oncology 190